Genital warts and vulvar intraepithelial neoplasia: Natural history and effects of treatment and human immunodeficiency virus infection

Obstetrics and Gynecology

Volumn 118, Issue 4, 2011, Pages 831-839

  Massad, L Stewart ^{a,b,c,d,e,f,g,h,i}   Xie, Xianhong ^{a,b,c,d,e,f,g,h,i}   Darragh, Teresa ^{a,b,c,d,e,f,g,h,i}   Minkoff, Howard ^{a,b,c,d,e,f,g,h,i}   Levine, Alexandra M ^{a,b,c,d,e,f,g,h,i}   Watts, D Heather ^{a,b,c,d,e,f,g,h,i}   Wright, Rodney L ^{a,b,c,d,e,f,g,h,i}   D'Souza, Gypsyamber ^{a,b,c,d,e,f,g,h,i}   Colie, Christine ^{a,b,c,d,e,f,g,h,i}   Strickler, Howard D ^{a,b,c,d,e,f,g,h,i}  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ARTICLE; BIOPSY; CANCER GRADING; CANCER SURGERY; CD4 LYMPHOCYTE COUNT; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; ELECTROSURGERY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; SMOKING; TOPICAL TREATMENT; VAGINAL INTRAEPITHELIAL NEOPLASIA; VULVA BIOPSY;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CONDYLOMATA ACUMINATA; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; RISK; SMOKING; VULVAR NEOPLASMS;

EID: 80053349385     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31821a0f4d     Document Type: Article

References (20)

1. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and highrisk HIV-negative women. J Natl Cancer Inst 1999;91:226-36. (Pubitemid 29090991)
2. Cubie HA, Seagar AL, Beattie GJ, Monaghan S, Williams ARW. A longitudinal study of HPV detection and cervical pathology in HIV infected women. Sex Transm Infect 2000; 76:257-61.
3. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency viruspositive women. J Natl Cancer Inst 2005;97:577-86. (Pubitemid 40723785)
4. Massad LS, Seaberg EC, Wright RL, Darragh T, Lee YC, Colie C, et al. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up. Obstet Gynecol 2008;111:1388-93.
5. Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol 2006;107:1023-8.
6. Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, et al. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol 2004;190:1241-8. (Pubitemid 38692204)
7. Dolev JC, Maurer T, Springer G, Glesby MJ, Minkoff H, Connell C, et al. Incidence and risk factors for verrucae in women. AIDS 2008;22:1213-9.
8. Barkan SE, Melnick SL, Martin-Preston S, Weber K, Kalish LA, Miotti P, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998;9:117-25. (Pubitemid 28157608)
9. Bacon M, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, et al. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 2005;12:1013-9. (Pubitemid 41324530)
10. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
11. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-73.
12. Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, Massad LS, et al. Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev 2010;19:159-69.
13. Sahai H, Khurshid A. Statistics in epidemiology: methods, techniques, and applications. Boca Raton (FL): CRC Press; 1996.
14. Berkson J, Gage R. Calculation of survival rates for cancer. Mayo Clin Proc 1950;25:270-86.
15. De Panfilis G, Melzani G, Mori G, Ghidini A, Graifemberghi S. Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls. Sex Transm Dis 2002;29:121-5. (Pubitemid 34219624)
16. Simard EP, Pfeiffer RM, Engels EA. Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med 2010;170:1337-45.
17. Dedes KJ, Beneder C, Samartzis N, Muller, Fink D, Fehr MK. Outcome of treated anogenital intraepithelial neoplasia among human immunodeficiency virus-infected women. J Reprod Med 2008;53:947-51.
18. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency viruspositive women. J Natl Cancer Inst 2005;97:577-86. (Pubitemid 40723785)
19. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminate and intraepithelial neoplasia: a prospective cohort study. Lancet 2002;359:108-13. (Pubitemid 34112538)
20. Garland SM, Steben M, Sings HL, James M, Lu Shuang, Railkar R, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009;199:805-14.